DECEMBER 18th Demand Medical Treatment for Mumia Abu-Jamal and 10,000 Prisoners with Hepatitis C in a landmark court hearing.
WHERE: William J. Nealon Federal Building, U.S. Court House, 235 N. Washington Ave., Scranton, PA 18501.
WHEN: 9:30am December 18, 2015
In
March 2015, Abu-Jamal was rushed to a hospital after collapsing from
near lethal blood sugar levels and renal failure. Even after treatment
for diabetes, he continued to suffer severe skin rashes and lesions over
much of his body as well as swelling of his arms and legs. His skin
developed a leatherlike appearance, and he had difficulty standing and
walking.
In August he was finally diagnosed with the hepatitis C virus, which impacts nearly 10,000 prisoners in Pennsylvania.
Despite
the diagnosis, prison officials refused to give Abu-Jamal a new
direct-acting anti-viral drug with a 90-95 percent cure rate for HCV.
The medication, manufactured by Gilead Sciences, comes with a hefty
price tag. At about $1,000 per pill, it costs $95,000 for a 12-week
course of treatment. Prison officials decided to hold off on treatment
until the final stages of the condition — in other words, when it would
be too late to save Mumia.
Speaking at a November meeting in
Philadelphia, Abu-Jamal’s attorney Robert Boyle noted that the cost of
the hospital care Mumia needed because the HCV went untreated was easily
double that expense.
For transportation from Philadelphia, call 215-724-1618 or email HepCcure4Mumiaallprisoners@gmx.com.
In New York call 212-330-8029.
If you are unable to get to Scranton, you can still show your support on Dec. 18 by calling:
PA Department of Corrections at 717-728-2573
PA Gov. Tom Wolf at 717-787-2500
Demand immediate hep C treatment for Mumia and 10,000 other prisoners.
WHERE: William J. Nealon Federal Building, U.S. Court House, 235 N. Washington Ave., Scranton, PA 18501.
WHEN: 9:30am December 18, 2015
In
March 2015, Abu-Jamal was rushed to a hospital after collapsing from
near lethal blood sugar levels and renal failure. Even after treatment
for diabetes, he continued to suffer severe skin rashes and lesions over
much of his body as well as swelling of his arms and legs. His skin
developed a leatherlike appearance, and he had difficulty standing and
walking.
In August he was finally diagnosed with the hepatitis C virus, which impacts nearly 10,000 prisoners in Pennsylvania.
Despite
the diagnosis, prison officials refused to give Abu-Jamal a new
direct-acting anti-viral drug with a 90-95 percent cure rate for HCV.
The medication, manufactured by Gilead Sciences, comes with a hefty
price tag. At about $1,000 per pill, it costs $95,000 for a 12-week
course of treatment. Prison officials decided to hold off on treatment
until the final stages of the condition — in other words, when it would
be too late to save Mumia.
Speaking at a November meeting in
Philadelphia, Abu-Jamal’s attorney Robert Boyle noted that the cost of
the hospital care Mumia needed because the HCV went untreated was easily
double that expense.
For transportation from Philadelphia, call 215-724-1618 or email HepCcure4Mumiaallprisoners@gmx.com.
In New York call 212-330-8029.
If you are unable to get to Scranton, you can still show your support on Dec. 18 by calling:
PA Department of Corrections at 717-728-2573
PA Gov. Tom Wolf at 717-787-2500
Demand immediate hep C treatment for Mumia and 10,000 other prisoners.
No comments:
Post a Comment